CD44 antibodies

Details for Australian Patent Application No. 2007338844 (hide)

Owner Medarex, Inc. Pfizer Inc.

Inventors Huang, Haichun; Yang, Lan; Badkar, Advait V.; Bedian, Vahe; Srinivasan, Mohan; Toy, Kristopher; Meaddough, Erika; Xu, Xu

Agent Allens Arthur Robinson

Pub. Number AU-A-2007338844

PCT Pub. Number WO2008/079246

Priority 60/876,109 21.12.06 US

Filing date 20 December 2007

Wipo publication date 3 July 2008

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079246 Priority application(s): WO2008/079246

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338853-Synthesis of unsaturated piperidines from piperidones with a silyl reagent

2007338843-Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof